Building the Future of Health Sciences
OrbiMed (orbimed.com) earns a Brand Analyzer score of 76 out of 100, placing it in the Brand-Ready tier among Finance brands, Healthcare brands. Among 2760 Finance brands analyzed, OrbiMed ranks in the 85th percentile (category average 69, leader 96). The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark. Dimension scores: Name Quality 100/100, Digital Presence 82/100, Visual Identity 95/100, Messaging Clarity 100/100, Trust Foundation 70/100, AI Discoverability 57/100, Brand Authority 45/100.
OrbiMed is a global investment firm founded in 1989 and headquartered in New York City, focused exclusively on the healthcare sector. The firm manages approximately $20 billion across public and private investments, employing over 150 experts who identify healthcare innovations worldwide. OrbiMed provides financing solutions to healthcare companies ranging from early-stage startups to large multinational corporations, operating across biopharmaceuticals, medical devices, digital health, diagnostics, and healthcare services.
| Brand Name | OrbiMed |
|---|---|
| Domain | orbimed.com |
| Industry | Finance, Healthcare |
| Founded | 1989 |
| Headquarters | New York City, New York |
| Main Competitors | Deerfield Management, RA Capital Management, Sofinnova Partners, Baker Bros. Advisors, Perceptive Advisors, Sectoral Asset Management |
Moz Domain Authority 43/100 vs category average 31 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
Ranked #1,889,796 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
OrbiMed has a dedicated Wikipedia entity - a top-weighted signal AI models rely on to identify and describe the brand.
The homepage meta description reads "OrbiMed invests in healthcare innovations to help humanity live healthier, longer, and more productive lives." (No meta description) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 1 JSON-LD block(s), Breadcrumb/Website schema, og:title, og:type, Twitter cards, canonical. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Social footprint: verified profiles on LinkedIn, Instagram, YouTube, GitHub; no detected presence on X (Twitter), Facebook - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
OrbiMed scores 56/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
OrbiMed has a limited AI-visibility profile at 56/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (65/100) and its weakest is trust (37/100). It benefits from a recognised Wikipedia company entity, a Wikidata knowledge-graph entry and a global traffic rank of #1,889,796 (Tranco). The main gaps holding it back: thin schema.org structured data and no llms.txt to steer AI to its best pages.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
OrbiMed's main competitors include Deerfield Management, RA Capital Management, Sofinnova Partners, Baker Bros. Advisors, Perceptive Advisors. These companies compete in the Finance space for similar customers, offering comparable products or services.
Sources: OrbiMed official site
OrbiMed offers investment and financing services tailored to the healthcare sector. Specifically, the firm provides tailored financing solutions and deploys global team resources to support the development of healthcare companies. Its investment activities span both public and private markets, covering early-stage companies through to large multinational corporations. Sectors covered include biopharmaceuticals, medical devices, digital health, diagnostics, and healthcare services. The firm manages approximately $20 billion across these investment strategies, leveraging a team of over 150 experts worldwide.
Sources: OrbiMed official site
OrbiMed is a leading global investment firm exclusively focused on the healthcare sector, headquartered in New York City, New York. Founded in 1989, the firm manages approximately $20 billion across both public and private investments. It operates with a team of over 150 experts who scout healthcare innovations worldwide. OrbiMed covers the full spectrum of healthcare investment, from early-stage companies to large multinational corporations, spanning biopharmaceuticals, medical devices, digital health, diagnostics, and healthcare services.
Sources: OrbiMed official site
OrbiMed invests in healthcare innovations with the stated mission of helping humanity live healthier, longer, and more productive lives. The firm provides tailored financing solutions and leverages its global team resources to help build world-class healthcare companies. It manages approximately $20 billion across public and private investments, with more than 150 experts identifying and evaluating healthcare innovations globally. OrbiMed engages with companies at various stages, from early-stage ventures to established multinational corporations, across sectors including biopharmaceuticals, medical devices, digital health, diagnostics, and healthcare services.
Sources: OrbiMed official site
Popular alternatives to OrbiMed include Deerfield Management, RA Capital Management, Sofinnova Partners, Baker Bros. Advisors, Perceptive Advisors. Each is an established option in the Finance space; the best fit depends on your specific needs, budget, and required features.
Sources: OrbiMed official site
OrbiMed has moderate AI-search visibility, scoring 56/100 on Brand Analyzer's AI visibility composite (visibility 63, trust 37, recommendation 65). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: OrbiMed official site
OrbiMed was founded in 1989. OrbiMed operates in the Finance category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
OrbiMed and Deerfield Management are competitors in Finance. They target overlapping audiences; the right choice depends on your specific needs and priorities.
Sources: OrbiMed official site
OrbiMed is known for being a leading global investment firm dedicated exclusively to the healthcare sector. It is recognized for managing approximately $20 billion across public and private healthcare investments, making it one of the largest dedicated healthcare investment firms in the world. The firm is also known for its extensive global reach, with over 150 experts scouting innovations worldwide, and for providing tailored financing solutions to healthcare companies ranging from early-stage startups to large multinational corporations.
Sources: OrbiMed official site
OrbiMed scores 65/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Finance options. Recommendation depends on crawlability, structured data, and category authority; a Wikipedia presence helps.
Sources: OrbiMed official site
OrbiMed can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: OrbiMed official site
OrbiMed's primary audience consists of healthcare innovators and companies seeking investment and financing. This includes organizations operating in biopharmaceuticals, medical devices, digital health, diagnostics, and healthcare services. The firm works with companies at various stages of development, from early-stage startups to established multinational corporations. As an investment firm managing public and private assets, OrbiMed also serves institutional investors who allocate capital to its funds, though the known facts focus primarily on healthcare companies as the direct recipients of OrbiMed's investment and support.
Sources: OrbiMed official site
Based on the available facts, OrbiMed's prominence appears to stem from its exclusive focus on healthcare investment, its significant scale of approximately $20 billion in assets under management, and its global team of over 150 experts. The firm's ability to provide tailored financing solutions across the full range of healthcare company stages-from early-stage innovators to multinational corporations-and its broad sector coverage including biopharmaceuticals, medical devices, digital health, diagnostics, and services, positions it as a go-to investment partner for healthcare companies globally.
Sources: OrbiMed official site
Ranked closest to OrbiMed: Oppenheimer & Co. Inc. (76/100), OneDigital (76/100), Palisade (76/100), Paymentsense (76/100).
A step up - brands to learn from: State Street Investment Management (81/100), Sapiens (81/100).
Category leader: Mastercard (96/100).